Specialized Workshop Th2 - Thursday April 16, 2026: 7am to 5:30pm
"AGENDA - Cell-Based Assays - Latest Advances, Challenges and Solutions from Internationally Recognized Key Opinion Leaders"
| 07:00am-08:00am: | Start your day at WRIB with Networking Continental Breakfast in the Exhibit Room |
Session 1: Latest Development in Flow Cytometry Extended Sample Stability
Chair: Dr. Yi-Dong Lin, Director Cytometry Translational Biomarkers & Bioanalytics , Takeda| 08:00am-08:20am: |
Dr. Vilma Decman, Executive Director, Head of Cellular Biomarkers, GlaxoSmithKline "Whole Blood Preservation for Flow Cytometry Testing" |
| 08:20am-08:40am: |
Dr. Yongliang (Steve) Sun, Director Clinical Flow Cytometry, Bristol Myers Squibb "Extended Sample Stability for Flow Cytometry Assays: Recent Advancements and Novel Case Studies" |
| 08:40am-09:00am: |
Mr. Chad Stevens, Mass Cytometry POC Cellular Biomeasure & Principal Scientist, Pfizer "Innovations in Mass Cytometry & Imaging Mass Cytometry for Scaling Large Studies" |
| 09:00am-09:20am: |
Dr. Vilma Decman, Executive Director, Head of Cellular Biomarkers, GlaxoSmithKline
Dr. Yongliang (Steve) Sun, Director Clinical Flow Cytometry, Bristol Myers Squibb Mr. Chad Stevens, Mass Cytometry POC Cellular Biomeasure & Principal Scientist, Pfizer "Panel Discussions on Latest Development in Flow Cytometry Extended Sample Stability" |
| 09:20am-10:10am: | Networking Coffee Break with Morning Snacks in the Exhibit Room |
Session 2: Advanced ADA/NAb Cell-Based/Cytometry Assays
Chair: Dr. James Huleatt, Senior Director Bioanalytical Sciences, Ethyreal Bio| 10:10am-10:30am: |
Dr. Daniela Verthelyi, Division Director Laboratory of Innate Immunity & Immunogenicity, ex US FDA "Multiplexed Immunophenotyping of Innate Immune Activation Detects Single-Cell Responses to Immunomodulatory Impurities in Therapeutics" |
| 10:30am-10:50am: |
Dr. Michele Rasamoelisolo, Senior Director Bioanalyticals, Teva "A Novel Neutralizing Antibody Assay Platform to Enhance Clinical Impact Assessment" |
| 10:50am-11:10am: |
Dr. Kelly Hainline , Senior Advisor Clinical Immunogenicity & Biomarker Assay Development, Lilly "A platform cell-based method for detection of neutralizing antibodies against incretin analog molecules" |
| 11:10am-11:30am: |
Dr. Lili Liao, Director Biologics Service, Frontage "Cell-based NAb Assays: Context-of-use (COU) for Distinct Readouts" |
| 11:30am-11:50am: |
Dr. Daniela Verthelyi, Division Director Laboratory of Innate Immunity & Immunogenicity, ex US FDA
Dr. Michele Rasamoelisolo, Senior Director Bioanalyticals, Teva Dr. Kelly Hainline , Senior Advisor Clinical Immunogenicity & Biomarker Assay Development, Lilly Dr. Lili Liao, Director Biologics Service, Frontage "Panel Discussions on Advanced ADA/NAb Cell-Based/Cytometry Assays" |
Session 3: Global Harmonization of Spectral Flow Cytometry and Innovation in RO/TE Assays
Chair: Dr. Paul Trampont, Senior Director, Global Lead Clinical Biomarker Laboratory, Moderna| 11:50am-12:10pm: |
Dr. Michael Nathan Hedrick, Senior Director Clinical Flow Cytometry, Bristol Myers Squibb "Clean, High Quality Flow Cytometry Data is the Result of True Harmony" |
| 12:10pm-01:10pm: |
Sit-down Networking Lunch downstairs at Marsalis B Note: Lunch Desserts and Coffee/Tea are served in the Exhibit Room |
| 01:10pm-01:30pm: |
Dr. Bill O'Gorman, Director Clinical Cytometry, Genentech "Tissue Receptor Occupancy: Assay Optimization and De-Risking for Clinical Implementation" |
| 01:30pm-01:50pm: |
Ms. Laïla-Aïcha Hanafi, Director Global Assay Development, CellCarta "Receptor Occupancy Assays for Clinical Analysis How to Build flexible and robust Spectral Flow Cytometry Panels" |
| 01:50pm-02:10pm: |
Dr. Michael Nathan Hedrick, Senior Director Clinical Flow Cytometry, Bristol Myers Squibb
Dr. Bill O'Gorman, Director Clinical Cytometry, Genentech Ms. Laïla-Aïcha Hanafi, Director Global Assay Development, CellCarta "Panel Discussions on Global Harmonization of Spectral Flow Cytometry and Innovation in RO/TE Assays " |
Session 4: State-of-the-art Analysis for Treg Clusters, Single-Cell Level by Mass/Flow Cytometry & ELISpot
Chair: Dr. Nathan Standifer, Executive Director Translational Medicine, Vera| 02:10pm-02:30pm: |
Mr. Luis Mendez, Director Flow Cytometry, Merck "Validation of a 29‑color Treg‑centric spectral flow assay and cross‑platform algorithmic analysis for autoimmune clinical trials" |
| 02:30pm-02:50pm: |
Mr. Pedro Falcon Estrada, Mass Cytometry Team Lead & Senior Scientist, Regeneron "Optimization of single-cell mass cytometry analytical platform for CAR-T Drug Product Characterization" |
| 02:50pm-03:10pm: |
Dr. Marie-Soleil Piche, Senior Director Immunology , Charles River "Leveraging Multiparameter Flow Cytometry and ELISpot to Identify and Characterize Vaccine‑Induced CD8⁺ T‑Cell Subpopulations" |
| 03:10pm-04:10pm: |
Networking Break with Afternoon Snacks, and Wine and Beer Reception in the Exhibit Room |
| 04:10pm-04:30pm: |
Mr. Luis Mendez, Director Flow Cytometry, Merck
Mr. Pedro Falcon Estrada, Mass Cytometry Team Lead & Senior Scientist, Regeneron Dr. Marie-Soleil Piche, Senior Director Immunology , Charles River "Panel Discussions on State-of-the-art Analysis for Treg Clusters, Single-Cell Level by Mass/Flow Cytometry & ELISpot" |
Session 5: 2026 White Paper in Bioanalysis
| 04:30pm-05:30pm: |
Dr. Yi-Dong Lin, Director Cytometry Translational Biomarkers & Bioanalytics , Takeda Dr. James Huleatt, Senior Director Bioanalytical Sciences, Ethyreal Bio Dr. Paul Trampont, Senior Director, Global Lead Clinical Biomarker Laboratory, Moderna Dr. Nathan Standifer, Executive Director Translational Medicine, Vera "Recommendations on Cell-Based & Flow Cytometry Assays and Panel Discussions for 2026 White Paper in Bioanalysis" |
